{"id":"NCT00123955","sponsor":"Wake Forest University","briefTitle":"PIE II: Pharmacological Intervention in the Elderly II","officialTitle":"Exercise Intolerance in Elderly Diastolic Heart Failure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-04","primaryCompletion":"2009-06","completion":"2012-12","firstPosted":"2005-07-26","resultsPosted":"2015-02-23","lastUpdate":"2019-02-27"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diastolic Heart Failure","Heart Failure, Congestive"],"interventions":[{"type":"DRUG","name":"Spironolactone","otherNames":["Aldactone"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to examine whether spironolactone will improve exercise tolerance and quality of life in elderly patients with heart failure preserved ejection fraction (HFPEF).","primaryOutcome":{"measure":"Exercise Intolerance","timeFrame":"Baseline, 4 and 9 months","effectByArm":[{"arm":"Spironolactone","deltaMin":13.5,"sd":2.9},{"arm":"Placebo","deltaMin":13.3,"sd":2.9}],"pValues":[]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["12413374","2007704","11179524","11094035","10471456","11835920","23150511","19379452"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":42},"commonTop":[]}}